Although fetal glucose and insulin levels were not evaluated on PD 19, fetal hyperinsulinemia has been reported in the offspring of STZ-treated dams in late pregnancy (33) and might contribute to the programming of macrosomia and obesity vulnerability later in life (8, 16). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.